Previous 10 | Next 10 |
The following slide deck was published by Cullinan Oncology, Inc. in conjunction with this event. For further details see: Cullinan Oncology (CEGM) Investor Presentation - Slideshow
CAMBRIDGE, Mass., April 07, 2021 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”) announced today that the company’s Chief Financial Officer, Jeff Trigilio, will present at the upcoming 20 th Annual Needham Virtual Healthcare Conference. ...
Cullinan Oncology (CGEM): FY net loss of $59.5MCash, cash equivalents and short-term investments of $210.2MPress Release For further details see: Cullinan Oncology reports FY results
Pipeline Progress: Clinical and preclinical programs continue to advance, with encouraging initial Cullinan Pearl data and additional INDs to be filed in 2021 for immuno-oncology assets Cullinan Florentine and Cullinan MICA Balance Sheet: Completion of Series C financing ($131.2...
CAMBRIDGE, Mass., March 02, 2021 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”), a biopharmaceutical company focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies, today announced that the company’s ...
February 22, 2021 Enrollment expansion in CLN-081 NSCLC EGFRex20ins Phase 1/2a trial Cullinan withdraws IND application for CLN-049 in Relapsed/Refractory AML CLN-619 IND submission planned for the second quarter of 2021 Cullinan to present at SVB Leerink Conference Febr...
Zai Lab ([[ZLAB]] +2.8%) is up ~2.7% after Jefferies rated the stock with a buy citing ‘huge biotech tailwinds’ in China where, according to analysts, the biopharma drug market is set to reach $80B in this decade from $30B.The price target derived from a combination of sum-of-th...
Point Roberts, WA and Delta, BC - February 5, 2021 (Investorideas.com Newswire) Investorideas.com , a global news source and leading retail investor and trader resource, announces its weekly roundup of stocks to watch in Biotech, Crypto, Cannabis, Tech, Gaming, Pets and Automotive. Toda...
Cullinan Management (CGEM) has gained ~60.8% since its IPO in January. That has not discouraged the H.C. Wainwright analyst Edward White to initiate the coverage with a buy rating and a price target of $47, an upside of ~39.2% to the previous close.‘The diversity of the products in the...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week ahead The stock market tries to reset after its worst week since October with even popular stocks like Apple (NASDAQ:AAPL) and...
News, Short Squeeze, Breakout and More Instantly...
Cullinan Oncology Inc. Company Name:
CGEM Stock Symbol:
OTCMKTS Market:
Cullinan Oncology Inc. Website:
2024-06-30 11:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
CAMBRIDGE, Mass., June 01, 2024 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc . (Nasdaq: CGEM), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced positive initial data in patients receiving zipalertinib after prior treatment with amivanta...
2024-05-29 21:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...